Abstract

Medication Therapy Management (MTM) service provided by pharmacists aims at optimizing drug therapy and improving therapeutic outcomes for patients. The objective of this study was to assess the knowledge, attitude and practice of MTM among hospital pharmacists in Delta State Nigeria. The study was a cross-sectional, descriptive survey. Overall, 115 copies of a validated 20 item questionnaire were distributed to hospital pharmacists in major towns in Delta state. Verbal consent was obtained from the respondents prior to administering the questionnaire. The filled questionnaires were collected, sorted and analysed. A total of 100 pharmacists participated in the study, of which 52 were females. The response rate was 86.96%; 94% of the respondents had a good knowledge of MTM. Most of the respondents felt that MTM encourages collaboration and cooperation between pharmacists and other health care professionals (95%), while 97% were willing to promote MTM in their hospital pharmacies. A total of 89 respondents use MTM tools to communicate and collaborate with other health care professionals to achieve optimal treatment outcomes. In conclusion, majority of the pharmacists had good knowledge of MTM, were willing to promote MTM and a few have started providing the service.

Keywords: Pharmacy Practice; Hospital Pharmacists’ Services; Nigeria, Medication Therapy Management; Medication Reconciliation; Pharmaceutical Care

References

1. Bluml BM. “Definition of medication therapy management: development of profession wide consensus”. Journal of the American Pharmacists Association 45 (2005): 566-572.
2. Hepler CD and Strand L M. “Opportunities and responsibilities in Pharmaceutical Care”. The American Journal of Health-System Pharmacy 47 (1990): 533-543.
3. Oparah AC. “Essentials of Pharmaceutical Care”. All Deals Investment Company Limited 11 (2010): 83-89.
4. Baltazar A. What is Medication Therapy Management? (2014).
5. Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service Model. Version 2.0. Washington, DC: American Pharmacists Association; National Association of Chain Drug Stores Foundation (2008): 7-13.
6. Wagner EH. “Chronic disease management: What will it take to improve care for chronic illness?” Effective Clinical Practice1 (1998): 2-4.
7. Garrett D and Bluml B. “Patient self-management program for diabetes: first- year clinical, humanistic, and economic outcomes”. Journal of the American Pharmacists Association 45 (2005): 130-137.
8. American Pharmacist Association. “National Association of Chain Drug Stores Foundation”. Journal of the American Pharmacists Association 3 (2008): 341-353.
9. Zachariah S., et al. “Rational Drug Use, Formulary Management, Pharmaceutical Care/Medication Therapy Management/Pharmacists Patient Care Process”. Clinical Pharmacy Education, Practice and Research; Elsevier Publication 5 (2019): 59-77.
10. McGivney SM., et al. “Medication Therapy Management: Its relationship to patient counselling, disease management and Pharmaceutical Care”. Journal of the American Pharmacists Association 47 (2007): 620-628.
11. Moczygemba LR., et al. “Texas pharmacists’ opinions about and plans for provision of Medication Therapy Management services”. Journal of the American Pharmacists Association 1 (2008): 38-45.
12. Urmie JM., et al. “Pharmacy students’ knowledge of the Medicare drug benefit and intention to provide Medicare Medication Therapy Management services”. American Journal of Pharmaceutical Education 3 (2007): 41.
13. Herbert KE., et al. “Prediction of pharmacist intention to provide Medicare Medication Therapy Management services using the theory of planned behaviour”. Research in Social and Administrative Pharmacy 3 (2006): 299-314.
14. Blake KV and Madhavan SS. “Perceived barriers to provision of Medication Therapy Management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS”. Annals of Pharmacotherapy 3 (2010): 424-431.
15. Lenaghan E., et al. “Home-based medication review in a high risk elderly population in primary care –the POLYMED randomised controlled trial”. Age and Ageing 36 (2007): 292-297.
16. Ponniah A., et al. “Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review”. Journal of Clinical Pharmacology and Therapeutics 32 (2007): 343-352.
17. Ackerman E., et al. “Pharmacists in general practice – a proposed role in the multidisciplinary team”. Australian Family Physician 39 (2010): 163-164.
18. Berger BA. “Interacting with physicians”. In: Communication Skills for Pharmacists. 2^nd Washington, DC: American Pharmacists Association (2005): 131-139.
19. Bunting BA and Cranor CW. “The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma”. Journal of the American Pharmacists Association 46 (2003): 133-147.
20. Cranor CW., et al. “The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program”. Journal of the American Pharmacists Association 43 (2003): 173-190.
21. Effective Health Care program. Medication Therapy Management (2013).
22. Ernst FR and Grizzle AJ. “Drug-related morbidity and mortality: Updating the cost-of illness model”. Journal of the American Pharmacists Association 41 (2001): 192-199.
23. Jameson J., et al. “The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy”. The Journal of Family Practice 5 (1995): 469-472.
24. Joan Dan Vanzo., et al. “Medication Therapy Management Services: A Critical Review”. American Pharmacists Association (2005): 9-10.
25. Johnson JA and Bootman JL. “Drug related morbidity and mortality and the economic impact of Pharmaceutical Care”. American Journal of Health-System Pharmacy 54 (1997): 554-558.
26. Johnson JA and Bootman JL. “Drug related morbidity and mortality: A cost of Illness Model”. Archives of General Internal Medicine 155 (1995): 1949-1956.
27. Lipton HL., et al. “The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing”. Med Care 30 (1992): 646-658.
28. Medicare Prescription Drug, Improvement and Modernization Act of Public Law 108 (2003): 173.
29. Plumridge RJ and Worjnar-Horton RE. “A review of the pharmacoeconomics of pharmaceutical care”. Pharmacoeconomics 2 (1998): 175-189.
30. Rovers J., et al. “The case for pharmaceutical care”. In: A Practical Guide to Pharmaceutical Care. 2^nd Washington, DC: American Pharmacists Association (2003): 3-4.
31. Rupp MT. “Value of the community pharmacists’ interventions to correct prescribing errors”. 26 (1992): 1580-1584.
32. Schultz H., et al. “Patient-perceived value of Medication Therapy Management (MTM) services: a series of focus groups (2012): 5-6.
33. Schumock GT., et al. “Evidence of the economic benefit of clinical pharmacy services: 1996–2000”. Annals of Pharmacotherapy 23 (2003): 113-132.
34. Smith W. “Excellence in the management of clinical pharmacy services”. The American Journal of Health-System Pharmacy 45 (1988): 319-325.
35. Tomechko MA., et al. “Q and A from the pharmaceutical care project in Minnesota”. American Pharmaceutical 35 4 (1995): 30-39.
36. Zierler-Brown S., et al. “Clinical Documentation for Patient Care: Models, Concepts, and Liability Considerations for Pharmacists”. American Journal of Health-System Pharmacy 64 (2007): 1851-1858.

Citation

Citation: Akonoghrere Rita., et al. “Knowledge, Attitude and Practice of Medication Therapy Management among Hospital Pharmacists in Delta State, Nigeria” Acta Scientific Pharmaceutical Sciences 4.8 (2020): 118-126.

Copyright

Copyright: © 2020 Akonoghrere Rita., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.